These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32320782)

  • 1. Prognostic value of cardiovascular magnetic resonance T1 mapping techniques in non-ischemic dilated cardiomyopathy: A systematic review and meta-analysis.
    Kiaos A; Antonakaki D; Bazmpani MA; Karvounis C; Rimoldi O; Karamitsos TD
    Int J Cardiol; 2020 Aug; 312():110-116. PubMed ID: 32320782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T1 Mapping and Extracellular Volume Fraction in Dilated Cardiomyopathy: A Prognosis Study.
    Li S; Zhou D; Sirajuddin A; He J; Xu J; Zhuang B; Huang J; Yin G; Fan X; Wu W; Sun X; Zhao S; Arai AE; Lu M
    JACC Cardiovasc Imaging; 2022 Apr; 15(4):578-590. PubMed ID: 34538631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy.
    Nakamori S; Dohi K; Ishida M; Goto Y; Imanaka-Yoshida K; Omori T; Goto I; Kumagai N; Fujimoto N; Ichikawa Y; Kitagawa K; Yamada N; Sakuma H; Ito M
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):48-59. PubMed ID: 28624408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of T1 mapping and extracellular volume fraction in cardiovascular disease: a systematic review and meta-analysis.
    Zhuang B; Sirajuddin A; Wang S; Arai A; Zhao S; Lu M
    Heart Fail Rev; 2018 Sep; 23(5):723-731. PubMed ID: 29968223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac MRI for clinical dilated cardiomyopathy: Improved diagnostic power via combined T1, T2, and ECV.
    Jia SQ; Lv SY; Jin YH; Zhao Y; Tian LP; Chang MM; Yan CL; Qi XL
    Radiography (Lond); 2024 May; 30(3):926-931. PubMed ID: 38657385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Native T1 time and extracellular volume fraction in differentiation of normal myocardium from non-ischemic dilated and hypertrophic cardiomyopathy myocardium: A systematic review and meta-analysis.
    Minegishi S; Kato S; Takase-Minegishi K; Horita N; Azushima K; Wakui H; Ishigami T; Kosuge M; Kimura K; Tamura K
    Int J Cardiol Heart Vasc; 2019 Dec; 25():100422. PubMed ID: 31517037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparison of short-term prognostic value of T1 mapping with feature tracking by cardiovascular magnetic resonance in patients with severe dilated cardiomyopathy.
    Chen R; Wang J; Du Z; Juan YH; Chan CW; Fei H; Xie J; Wu W; Zhu Y; Li L; Meng J; Wu S; Liang C; Yu Z; Liu H
    Int J Cardiovasc Imaging; 2019 Jan; 35(1):171-178. PubMed ID: 30132161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Native T1 heterogeneity for predicting reverse remodeling in patients with non-ischemic dilated cardiomyopathy.
    Kinoshita M; Kato S; Kodama S; Azuma M; Nakayama N; Fukui K; Saito N; Iwasawa T; Kimura K; Tamura K; Utsunomiya D
    Heart Vessels; 2022 Sep; 37(9):1541-1550. PubMed ID: 35320392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T1 and T2 mapping for early diagnosis of dilated non-ischaemic cardiomyopathy in middle-aged patients and differentiation from normal physiological adaptation.
    Mordi I; Carrick D; Bezerra H; Tzemos N
    Eur Heart J Cardiovasc Imaging; 2016 Jul; 17(7):797-803. PubMed ID: 26358692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reference Ranges, Diagnostic and Prognostic Utility of Native T1 Mapping and Extracellular Volume for Cardiac Amyloidosis: A Meta-Analysis.
    Wang TKM; Brizneda MV; Kwon DH; Popovic ZB; Flamm SD; Hanna M; Griffin BP; Xu B
    J Magn Reson Imaging; 2021 May; 53(5):1458-1468. PubMed ID: 33274809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [T1 mapping and late gadolinium enhancement for the diagnosis of dilated cardiomyopathy].
    Cui Q; Yu J; Ge X; Gao G; Liu Y; Shen W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1506-1510. PubMed ID: 33541506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy.
    aus dem Siepen F; Buss SJ; Messroghli D; Andre F; Lossnitzer D; Seitz S; Keller M; Schnabel PA; Giannitsis E; Korosoglou G; Katus HA; Steen H
    Eur Heart J Cardiovasc Imaging; 2015 Feb; 16(2):210-6. PubMed ID: 25246502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial extracellular volume fraction measurements with MOLLI 5(3)3 by cardiovascular MRI for the discrimination of healthy volunteers from dilated and hypertrophic cardiomyopathy patients.
    Cui Y; Chen Y; Cao Y; Liu J; Song J; Zhang S; Kong X; Han P; Shi H
    Clin Radiol; 2019 Sep; 74(9):732.e9-732.e16. PubMed ID: 31122714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of extracellular volume fraction by cardiac magnetic resonance imaging and QRS duration for the risk stratification for patients with non-ischemic dilated cardiomyopathy.
    Kodama S; Kato S; Hayakawa K; Azuma M; Kagimoto M; Iguchi K; Fukuoka M; Fukui K; Iwasawa T; Utsunomiya D; Kosuge M; Kimura K; Tamura K
    Heart Vessels; 2020 Oct; 35(10):1439-1445. PubMed ID: 32417957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver T1 Mapping Derived From Cardiac Magnetic Resonance Imaging: A Potential Prognostic Marker in Idiopathic Dilated Cardiomyopathy.
    Wang J; Diao Y; Xu Y; Guo J; Li W; Li Y; Wan K; Sun J; Han Y; Chen Y
    J Magn Reson Imaging; 2024 Aug; 60(2):675-685. PubMed ID: 38174826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study.
    Youn JC; Hong YJ; Lee HJ; Han K; Shim CY; Hong GR; Suh YJ; Hur J; Kim YJ; Choi BW; Kang SM
    Eur Radiol; 2017 Sep; 27(9):3924-3933. PubMed ID: 28439651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SASHA versus ShMOLLI: a comparison of T1 mapping methods in health and dilated cardiomyopathy at 3 T.
    Costello BT; Springer F; Hare JL; Gerche A; Iles L; Ellims AH; Schmitt B; Taylor AJ
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1551-1560. PubMed ID: 28589482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular volume fraction assessed using cardiovascular magnetic resonance can predict improvement in left ventricular ejection fraction in patients with dilated cardiomyopathy.
    Inui K; Asai K; Tachi M; Yoshinaga A; Izumi Y; Kubota Y; Murai K; Tsukada YT; Amano Y; Kumita S; Shimizu W
    Heart Vessels; 2018 Oct; 33(10):1195-1203. PubMed ID: 29560528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the cardiac magnetic resonance derived extracellular volume fraction and feature tracking myocardial strain in patients with non-ischemic dilated cardiomyopathy.
    Azuma M; Kato S; Kodama S; Hayakawa K; Kagimoto M; Iguchi K; Fukuoka M; Fukui K; Iwasawa T; Utsunomiya D; Kimura K; Tamura K
    Magn Reson Imaging; 2020 Dec; 74():14-20. PubMed ID: 32898651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular Magnetic Resonance Radiomics to Identify Components of the Extracellular Matrix in Dilated Cardiomyopathy.
    Nakamori S; Amyar A; Fahmy AS; Ngo LH; Ishida M; Nakamura S; Omori T; Moriwaki K; Fujimoto N; Imanaka-Yoshida K; Sakuma H; Dohi K; Manning WJ; Nezafat R
    Circulation; 2024 Jul; 150(1):7-18. PubMed ID: 38808522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.